XML 30 R16.htm IDEA: XBRL DOCUMENT

SUPPLEMENTAL FINANCIAL INFORMATION

12 Months Ended

Dec. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

SUPPLEMENTAL FINANCIAL INFORMATION

NOTE 6. SUPPLEMENTAL FINANCIAL INFORMATION

Balance Sheets

Accounts receivable, net

Accounts receivable, net consisted of the following:

Schedule of accounts receivable
		December 31,
		2024				2023

Accounts receivable (1)		$	18,326			$	13,270
Less: Allowance for doubtful accounts			–				–
Accounts receivable, net		$	18,326			$	13,270

(1)	Accounts receivable denominated in foreign currencies in the years ended 2024 and 2023 represent 11% and 39%, respectively.

Prepaids and other current assets


		December 31,
		2024				2023

Short term deposits		$	39,003			$	50,000
Deferred offering costs			119,730				100,588
Prepaid insurance D & O			96,578				34,769
Prepaid health insurance			16,715				–
Prepaid clinical			26,428				–
Prepaid annual fees			24,079				–
Prepaid insurance other			15,594				17,884
Prepaid, other			4,167				41,635
Other receivables			–				154
		$	342,292			$	245,030

Accounts payable

Schedule of accounts payable
		December 31,
		2024				2023

Accounts payable		$	525,582			$	758,821
Credit cards payable			6,021				1,714
		$	531,603			$	760,535

Accrued and other liabilities


		December 31,
		2024				2023

Accrued payroll		$	–			$	162,887
Accrued bonus			404,228				262,580
Accrued board compensation			46,250				92,500
Accrued audit and legal expenses			33,006				89,082
Investment banking and related fees			15,000				139,906
Accrued interest			–				98,685
Other accrued expenses			30,698				12,082
		$	529,182			$	857,722

Statements of Operations

Other expense, net consisted of the following:

Schedule of other expense
		Year Ended December 31,
Income/(Expense)		2024				2023

Bank Interest		$	318			$	172
Taxes			(–	)			(1,144	)
Foreign Currency Gain (Loss)			(49	)			145
Other			–				265
		$	269			$	(562	)